These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21205330)

  • 1. Prime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in mice.
    Zhou H; Guo L; Wang M; Qu J; Zhao Z; Wang J; Hung T
    Virol J; 2011 Jan; 8():3. PubMed ID: 21205330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant adenovirus prime-virus-like particle boost regimen elicits effective and specific immunities against norovirus in mice.
    Guo L; Zhou H; Wang M; Song J; Han B; Shu Y; Ren L; Si H; Qu J; Zhao Z; Wang J; Hung T
    Vaccine; 2009 Aug; 27(38):5233-8. PubMed ID: 19589399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.
    Parez N; Fourgeux C; Mohamed A; Dubuquoy C; Pillot M; Dehee A; Charpilienne A; Poncet D; Schwartz-Cornil I; Garbarg-Chenon A
    J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins.
    Schwartz-Cornil I; Benureau Y; Greenberg H; Hendrickson BA; Cohen J
    J Virol; 2002 Aug; 76(16):8110-7. PubMed ID: 12134016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles.
    Lappalainen S; Tamminen K; Vesikari T; Blazevic V
    Hum Vaccin Immunother; 2013 Sep; 9(9):1991-2001. PubMed ID: 23777748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.
    Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V
    Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.
    Lappalainen S; Pastor AR; Tamminen K; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
    Hum Vaccin Immunother; 2014; 10(7):2039-47. PubMed ID: 25424814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-peritoneal and intra-rectal immunogenicity induced by rotavirus virus like particles 2/6/7 in mice.
    Marashi SM; Jalilvand S; Mollaei-Kandelous Y; Shahmahmoodi S; Rezaei F; Salimi V; Nejati A; Validi M; Shoja Z
    Microb Pathog; 2014; 67-68():48-54. PubMed ID: 24583154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
    Siadat-Pajouh M; Cai L
    Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
    Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
    Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and efficacy in mice of an adenovirus-based bicistronic rotavirus vaccine expressing NSP4 and VP7.
    Xie L; Yan M; Wang X; Ye J; Mi K; Yan S; Niu X; Li H; Sun M
    Virus Res; 2015 Dec; 210():298-307. PubMed ID: 26368053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA.
    McNeal MM; Stone SC; Basu M; Bean JA; Clements JD; Hendrickson BA; Choi AH; Ward RL
    Virology; 2006 Mar; 346(2):338-47. PubMed ID: 16375942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral and intraperitoneal immunization with rotavirus 2/6 virus-like particles stimulates a systemic and mucosal immune response in mice.
    Shuttleworth G; Eckery DC; Awram P
    Arch Virol; 2005 Feb; 150(2):341-9. PubMed ID: 15578236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An oral versus intranasal prime/boost regimen using attenuated human rotavirus or VP2 and VP6 virus-like particles with immunostimulating complexes influences protection and antibody-secreting cell responses to rotavirus in a neonatal gnotobiotic pig model.
    Azevedo MS; Gonzalez AM; Yuan L; Jeong KI; Iosef C; Van Nguyen T; Lovgren-Bengtsson K; Morein B; Saif LJ
    Clin Vaccine Immunol; 2010 Mar; 17(3):420-8. PubMed ID: 20107005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G).
    Smiley KL; McNeal MM; Basu M; Choi AH; Clements JD; Ward RL
    J Virol; 2007 Apr; 81(8):3740-8. PubMed ID: 17251301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnitude of serum and intestinal antibody responses induced by sequential replicating and nonreplicating rotavirus vaccines in gnotobiotic pigs and correlation with protection.
    Azevedo MS; Yuan L; Iosef C; Chang KO; Kim Y; Nguyen TV; Saif LJ
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):12-20. PubMed ID: 14715539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine.
    Lappalainen S; Pastor AR; Malm M; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
    Arch Virol; 2015 Aug; 160(8):2075-8. PubMed ID: 26016444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies.
    García-Díaz A; López-Andújar P; Rodríguez Díaz J; Montava R; Torres Barceló C; Ribes JM; Buesa J
    Vaccine; 2004 Dec; 23(4):489-98. PubMed ID: 15530697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The assembly conformation of rotavirus VP6 determines its protective efficacy against rotavirus challenge in mice.
    Pastor AR; Rodríguez-Limas WA; Contreras MA; Esquivel E; Esquivel-Guadarrama F; Ramírez OT; Palomares LA
    Vaccine; 2014 May; 32(24):2874-7. PubMed ID: 24583002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
    Choi AH; Knowlton DR; McNeal MM; Ward RL
    Virology; 1997 May; 232(1):129-38. PubMed ID: 9185596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.